In August 2025, Bayer announced a study of researchers will check the medical history and current medications of the participants. They will also perform a complete health check-up of all the ...

Pascal Soriot, Chief Executive Officer, AstraZeneca, said:. As we enter our next phase of growth, we have pledged $50 billion to continue to grow in the US, which includes the largest ...

Astrazeneca has announced a surge in revenue from cancer drugs amidst speculation that its boss is considering a listing in the US. The company reported an 11 per cent rise in total revenue to $28bn ...

Core operating profit increased by 13 per cent while pre-tax profit climbed by 26 per cent to $6.5bn. Pascal Soriot, chief executive at AstraZeneca, said: "Our strong momentum in revenue growth ...

Astrazeneca has revealed a jump in revenue from cancer drugs amid rumours its boos is eyeing a listing across the pond. Total revenue rose 11 per cent to $28bn (£12.98bn) in the first half of the year ...

AstraZeneca reported 11% year-on-year revenue growth, excluding a 1% currency headwind, and core operating profit growth of 14%. Management reiterated its full-year guidance of high single-digit ...

The project will establish a new manufacturing facility in the United States to develop drugs for weight loss, including oral GLP-1, baxdrostat, oral PCSK9, and combined low-molecular-weight drugs.

Six or 9 months of bedaquiline, delamanid, linezolid, and clofazimine was not noninferior to longer standard of care.

The cornerstone of this landmark investment is a new multi-billion-dollar US manufacturing facility that will produce drug substances for the company’s innovative weight management and metabolic ...